Nicola Tarantino

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/870a5060-5fa7-11ec-9773-d197dc92a0d8.jpg

First Name

Nicola

Last Name

Tarantino

NPI

1669954558

Faculty ID

17681

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

13854

Visit Type ID

2497

Is Open Scheduling

Off

Zocdoc Link

Leandro N. Slipczuk Bustamante

https://assets.montefioreeinstein.org/profiles/images/Slipczuk_Leandro_MD_2x.jpg

First Name

Leandro

Last Name

Slipczuk Bustamante

NPI

1134431000

Faculty ID

16531

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Clinical focus is the treatment of coronary artery disease, familial hypercholesterolemia and lipid disorders in both prevention and established diseases, cardiometabolic disorders, hypertension, valvular heart disease and heart failure with a comprehensive clinical and multimodality imaging approach.

Research Focus

Dr. Slipczuk’s research focus is on the identification of high-risk patients and plaque features, lipid disorders, cardiovascular imaging and valvular heart disease.

Elsevier Profile

EMR ID

113938

Biography

<p>Leandro Slipczuk Bustamante, MD, PhD, FACC is a board certified cardiologist,&nbsp; Director of the Advanced Cardiac Imaging Program and the Cardiovascular Atherosclerosis and Lipid Disorder Center at Montefiore Cardiology Division. Additionally, Dr. Slipczuk is an Assistant Professor at our Albert Einstein College of Medicine. His clinical focus is the treatment of coronary artery disease, familial hypercholesterolemia and lipid disorders in both prevention and established diseases, cardiometabolic disorders, hypertension, valvular heart disease and heart failure with a comprehensive clinical and multimodality imaging approach.</p><p>In 2007, Dr. Slipczuk received his Doctor of Medicine from the University of Buenos Aires. He continued studying at this institution, and in 2010 received his Doctor of Philosophy. Dr. Slipczuk began his postgraduate training with a residency in internal medicine at Einstein Medical Center, which he completed in 2013. He then completed a fellowship in cardiology and advanced cardiovascular imaging in 2016 at Cedars-Sinai Medical Center.</p><p>Dr. Slipczuk&rsquo;s research focus is on the identification of high-risk patients and plaque features, lipid disorders, cardiovascular imaging and valvular heart disease. His work has been published in peer-reviewed journals and articles.</p><p>Dr. Slipczuk is board certified by the American Board of Clinical Lipidology and the American Board of Internal Medicine. He is also board certified in cardiovascular CT, comprehensive adult echocardiography and nuclear cardiology. He is an active member of the National Lipid Association where he is a member of the publications committee as well as the imaging and cardiometabolic working groups. He is also a Fellow of the American College of Cardiology and a member of the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Magnetic Resonance.</p>

Visit Type ID

2497

Is Open Scheduling

On

Zocdoc Link

Daniel B. Sims

https://assets.montefioreeinstein.org/profiles/images/physphoto/Sims_Daniel_MD_420x504.jpg

First Name

Daniel

Last Name

Sims

NPI

1548283112

Faculty ID

13920

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal">Daniel Sims, MD, FAHA, FACC, serves as the Program Director of the Cardiology Fellowship Training Program and is the Medical Director of the Moses Cardiac Intensive Care Unit (CICU). Dr. Sims is an Associate Professor of Medicine, Fellow of the American Heart Association (AHA), and Fellow of the American College of Cardiology (ACC). Originally from Bellmore, NY, Dr. Sims graduated from Yale University with a BA in history in 1999. He attended medical school at Emory University School of Medicine in Atlanta, GA, graduating in 2003. He stayed at Emory for his 3-year internal medicine internship and residency training, finishing in 2006. He was selected to stay an additional one year to serve as the chief resident at the Emory University Hospital. Dr. Sims did his 3-year cardiology fellowship at Columbia University Medical Center and served as chief cardiology fellow during his final year, finishing in 2010. He completed an additional one-year advanced heart failure and transplant cardiology fellowship at Columbia in 2011. Dr. Sims returned to Emory to serve on the cardiology faculty and as a member of the Center for Heart Failure Therapy and Transplantation.</p>
<p class="MsoNormal">After 2 years, Dr. Sims was recruited to Montefiore in 2013 to be the Medical Director for the Moses CICU and a member of the cardiac transplant and left ventricular assist device (LVAD) team. At Montefiore, Dr. Sims has been active in clinical research involving heart failure, cardiogenic shock, cardiac critical care, cardiac transplantation, and LVADs. He has mentored numerous residents and fellows on research projects. Dr. Sims served 2 2-year terms as a member of the AHA&rsquo;s Acute Cardiac Care Committee and has been a member of the AHA writing groups for scientific statements on neuroprognostication after cardiac arrest, management of fulminant myocarditis, the prevention of complications in the CICU, and escalating and de-escalating temporary mechanical circulatory support devices. Dr. Sims is a two-time winner of the Department of Medicine&rsquo;s Sharon R. Silbiger Faculty Teaching Award as the subspecialist of the year. Prior to becoming Program Director, Dr. Sims was a two-time winner of the Cardiology Fellowship Training Program &ldquo;Program Director&rsquo;s Training Award.&rdquo; Dr. Sims is board certified in Cardiology as well as in Advanced Heart Failure and Transplant Cardiology.&nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Sim's clinical focus has been the treatment of patients with acute and chronic heart failure due to multiple kinds of cardiomyopathy such as dilated, hypertrophic and restrictive, among others.&nbsp;

Research Focus

Dr. Sims&rsquo; research focuses on a number of topics, including the delivery of cardiac critical care and improving outcomes in the CICU and the use of temporary mechanical circulatory support with intra-aortic balloon pumps, Impella, percutaneous heart pumps, extracorporeal membrane oxygenation (ECMO) pumps and other devices to treat cardiogenic shock. He also aims to improve left ventricular assist device patient and heart transplant patient survival.&nbsp;

Elsevier Profile

EMR ID

5762

Biography

<p>Daniel Sims, MD, serves as the Program Director of the Cardiology Fellowship Training Program and is the Medical Director of the Moses Cardiac Intensive Care Unit (CICU). Dr. Sims is an Associate Professor of Medicine at our Albert Einstein College of Medicine, Fellow of the American Heart Association (AHA), and Fellow of the American College of Cardiology (ACC). Originally from Bellmore, NY, Dr. Sims graduated from Yale University with a BA in history in 1999. He attended medical school at Emory University School of Medicine in Atlanta, GA, graduating in 2003. He stayed at Emory for his 3-year internal medicine internship and residency training, finishing in 2006. He was selected to stay an additional one year to serve as the chief resident at the Emory University Hospital. Dr. Sims did his 3-year cardiology fellowship at Columbia University Medical Center and served as chief cardiology fellow during his final year, finishing in 2010. He completed an additional one-year advanced heart failure and transplant cardiology fellowship at Columbia in 2011. Dr. Sims returned to Emory to serve on the cardiology faculty and as a member of the Center for Heart Failure Therapy and Transplantation.</p><p>After 2 years, Dr. Sims was recruited to Montefiore in 2013 to be the Medical Director for the Moses CICU and a member of the cardiac transplant and left ventricular assist device (LVAD) team. His clinical focus has been the treatment of patients with acute and chronic heart failure due to multiple kinds of cardiomyopathy such as dilated, hypertrophic, and restrictive, among others. Dr. Sims also cares for patients with myocarditis, left ventricular assist devices, and cardiac transplants.</p><p>Dr. Sims has been active in clinical research involving heart failure, cardiogenic shock, temporary mechanical circulatory support devices, cardiac critical care, cardiac transplantation, and LVADs. He has mentored numerous residents and fellows on research projects and his work has been published in a number of peer-reviewed journals and textbooks. Dr. Sims served 2 2-year terms as a member of the AHA&rsquo;s Acute Cardiac Care Committee and has been a member of the AHA writing groups for scientific statements on neuroprognostication after cardiac arrest, management of fulminant myocarditis, the prevention of complications in the CICU, and escalating and de-escalating temporary mechanical circulatory support devices. Dr. Sims is a two-time winner of the Department of Medicine&rsquo;s Sharon R. Silbiger Faculty Teaching Award as the subspecialist of the year. Prior to becoming Program Director, Dr. Sims was a two-time winner of the Cardiology Fellowship Training Program &ldquo;Program Director&rsquo;s Training Award.&rdquo; Dr. Sims is a member of the AHA, the ACC, and the International Society of Heart and Lung Transplantation. Additionally, he is board certified in Cardiology as well as Advanced Heart Failure and Transplant Cardiology.</p>

Is Open Scheduling

Off

Nicholas E.S. Sibinga

https://assets.montefioreeinstein.org/profiles/images/Nicholas_Sibinga-MD-2x.jpg

First Name

Nicholas

Last Name

Sibinga

NPI

1275673154

Faculty ID

6761

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Vascular disease, the greatest single cause of morbidity and mortality in developed societies, results from interactions between circulating inflammatory cells, the endothelium that lines the vasculature, underlying vascular smooth muscle cells (VSMCs) that comprise most of the arterial wall, and stem/progenitor cells found in the surrounding adventitia. The underlying pathogenesis is complex: factors that impinge on these cell types include reactivated developmental pathways, innate and acquired immune responses, and changes in cell function that result from physical stresses, perturbed blood flow, and biochemical stimuli. Our general approach is to characterize these responses at the molecular level, in cultured cells, and in mouse models that reflect specific types of vascular injury, including atherosclerosis, mechanical trauma, and transplant-associated arteriosclerosis.</p>
<p>Fat proteins are important regulators of cell growth and planar cell polarity. We have linked the atypical cadherin adhesion molecule Fat1 to significant effects on mammalian vascular remodeling. Our studies in VSMCs show that Fat1 interacts with beta-catenin to limit canonical Wnt signaling, a core developmental pathway that regulates many aspects of metazoan embryogenesis, and with Atrophin proteins to control VSMC directional migration. Recent findings suggest that Fat1 is an important regulator of VSMC growth and differentiation in injured vessels, and ongoing studies aim to understand the intracellular and extracellular signals that emanate from Fat1 in cis- and trans-signaling modes. Direct studies of beta-catenin indicate that its expression in VSMCs is required for vascular formation in development and important in adult arterial injury response. Efforts to understand beta-catenin&rsquo;s essential function in these settings are underway.</p>
<p>Diabetes and obesity are important risk factors for cardiovascular disease. We are investigating how allograft inflammatory factor-1 (Aif-1), a 17 kD Ca2+-binding protein contributes to these conditions. Specific Aif-1 isoform-dependent functions that underlie effects on macrophage migration, phagocytosis, survival, and inflammatory signaling are subjects of ongoing studies. Finally, in collaboration with Richard Stanley, we have characterized a role for colony stimulating factor-1 (CSF-1), the main regulator of macrophage survival, proliferation, and differentiation, in control of transplant-associated arteriosclerosis, the major barrier to long-term success of organ transplants. Surprisingly, this effect appears to involve VSMC-associated CSF-1 in an autocrine/juxtacrine mechanism that is largely independent of macrophages.</p>
<p>Ongoing work in these areas involves defining the molecular bases for these observations. By identifying such novel mechanisms, we hope to find new targets for therapeutic intervention to improve vascular disease prevention and treatment.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">1.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Riascos-Bernal D, Chinnasamy P, Cao L, Dunaway CM, Valenta T, Basler K,&nbsp;Sibinga, NES.&nbsp;&beta;-Catenin C-terminal signals suppress p53 and are essential for artery formation.&nbsp;<em>Nature Communications,&nbsp;</em>2016 Aug 8;7:12389. PMID: 27499244</p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">2.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Cao L, Riascos-Bernal D, Chinnasamy P, Dunaway C, Pujato M, Fiser A,&nbsp;Sibinga NES. Control of mitochondrial function and cell growth by the atypical cadherin Fat1.<em>&nbsp;Nature</em>, 2016 Nov 9;539(7630):575-578. PMID: 27828948.</p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">3.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Riascos-Bernal DF, Chinnasamy P, Gross JN, Almonte V, Ega&ntilde;a-Gorro&ntilde;o L, Parikh D, Jayakumar S, Guo L,&nbsp;Sibinga NES. Inhibition of smooth muscle &beta;-catenin hinders neointima formation after vascular injury.&nbsp;<em>Arterioscler Thromb Vasc Biol,&nbsp;</em><span style="font-family: Times;">2017 May;37(5):879-888. PMID: 28302627.</span></p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">4.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family: Times;">Ega&ntilde;a-Gorro&ntilde;o L, Chinnasamy P, Casimiro I, Almonte VM, Parikh D, Oliveira-Paula^&nbsp;GH, Jayakumar S, Law C, Riascos-Bernal DF,&nbsp;Sibinga NES. Allograft Inflammatory Factor-1 Supports Macrophage Survival and Efferocytosis and Limits Necrosis in Atherosclerotic Plaques.&nbsp;<em>Atherosclerosis</em>, 2019&nbsp;Oct;289:184-194. PMID: 31439353.</span></p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">5.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family: Times;">Becher T, Riascos-Bernal DF, Kramer DJ, Almonte VM, Chi J, Tong T, Oliveira-Paula GH, Koleilat I, Chen W, Cohen P, Sibinga NES. Three-Dimensional Imaging Provides Detailed Atherosclerotic Plaque Morphology and Reveals Angiogenesis after Carotid Artery Ligation. Circ Res. 2020 Feb 28;126(5):619-632. PMID: 31914850. PMCID: PMC7047629.</span></p>
<p class="MsoNormal" style="margin: 0in 4.3pt 6pt 0.75in; font-size: 12pt; font-family: Calibri, sans-serif; text-indent: -0.25in;"><span style="font-family: 'Times New Roman', serif;">6.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family: 'Times New Roman', serif;">Parikh D, Riascos-Bernal DF, Ega&ntilde;a-Gorro&ntilde;o L, Jayakumar S, Almonte V, Chinnasamy P, Sibinga NES. Allograft inflammatory factor-1-like is not essential for age dependent weight gain or HFD-induced obesity and glucose insensitivity. <em>Sci Rep.</em> 2020 Feb 27;10(1):3594. PMID:&nbsp;32107417. PMCID: PMC7046694.</span></p>
<p class="MsoNormal" style="margin: 0in 4.3pt 6pt 0.75in; font-size: 12pt; font-family: Calibri, sans-serif; text-indent: -0.25in;"><span style="font-family: 'Times New Roman', serif;">7.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family: 'Times New Roman', serif;">Chen W, Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Riascos-Bernal DF, Wu TT, Qiu Y, Kurland IJ, Dubin RF, Chen Y, Parekh RS, Bushinsky DA, Sibinga NES. Identification of Novel Biomarkers and Pathways for Coronary Artery Calcification in Nondiabetic Patients on Hemodialysis Using Metabolomic Profiling. Kidney360. 2021 February;2(2):279-289. PubMed PMID: 34723191; PubMed Central PMCID: PMC8553022; DOI: 10.34067/kid.0004422020.</span></p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">8.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Almonte VM, Uriyanghai U, Ega&ntilde;a-Gorro&ntilde;o L, Parikh D, Oliveira-Paula GH, Zhang J, Jayakumar S, Riascos-Bernal DF,&nbsp;Sibinga NES.&nbsp;PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodeling.&nbsp;<em>Cardiovasc Res.</em>&nbsp;2021 Sep 3:cvab289. doi: 10.1093/cvr/cvab289. Online ahead of print. PMID: 34478521.</p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">9.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Lituma PJ, Woo E, O&rsquo;Hara BF, Castillo PE,&nbsp;Sibinga NES,&nbsp;Nandi S. Altered synaptic connectivity and brain function in mice lacking microglial adapter protein Iba1.&nbsp;<em>Proc Nat Acad Sci U S A. 2021</em>, Nov 16;118(46):e2115539118.&nbsp;&nbsp;doi: 10.1073/pnas.2115539118. PMID: 34764226. PMCID: PMC8609554.</p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">10.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp; </span></span>Riascos-Bernal DF, Maira A,&nbsp;Sibinga NES.&nbsp;The Atypical Cadherin FAT1 Limits Mitochondrial Respiration and Proliferation of Vascular Smooth Muscle Cells.&nbsp;<em>Front Cardiovasc Med.</em>&nbsp;2022 May 11;9:905717. doi: 10.3389/fcvm.2022.905717. PMID: 35647082</p>
<p class="MsoListParagraph" style="margin: 0in 13.7pt 6pt 0.75in; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: -0.25in;"><span style="font-family: Times;">11.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp; </span></span><span style="font-family: Times;">Parikh D, Jayakumar S, Oliveira-Paula GH, Almonte V, Riascos-Bernal DF,&nbsp;Sibinga NES.&nbsp;Allograft inflammatory factor-1-like is a situational regulator of leptin levels, hyperphagia, and obesity.&nbsp;<em>iScience</em>. 2022 Sep 3;25(10):105058. doi: 10.1016/j.isci.2022.105058. eCollection 2022 Oct 21. PMID: 36134334&nbsp;</span></p>

EMR ID

4369

Is Open Scheduling

Off

Jooyoung (Julia) Shin

https://assets.montefioreeinstein.org/profiles/images/physphoto/Shin_Jooyoung_MD_420x504.jpg

First Name

Jooyoung (Julia)

Last Name

Shin

NPI

1821037961

Faculty ID

10716

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p align="left" style=" word-break: normal; text-align: left;"><span style=" color: black; font-size: 12.0pt; font-family: 'Times New Roman';">Clinical cardiology, specifically end-stage congestive heart failure, mechanical circulatory support, and cardiac transplantation.&#160;&#160;</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Shin's clinical focus is on caring for patients with heart failure, particularly providing expertise in advanced heart failure, heart transplantation, and mechanical circulatory support.

Research Focus

Heart failure treatment is the primary focus of Dr. Shin&rsquo;s research. She is the site principal investigator for the effectiveness of omecamtiv mecarbil/AMG 423 to treat chronic heart failure with reduced ejection fraction (GALACTIC-HF) and multiple cardiac sensors for the management of heart failure (MANAGE-HF) trials.

Elsevier Profile

EMR ID

4843

Biography

<p>Jooyoung Julia Shin, MD, is Fellowship Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program and Associate Professor, Medicine at Montefiore Einstein. Dr. Shin&rsquo;s clinical focus centers on heart failure, cardiac transplantation and mechanical circulatory support.</p><p>After obtaining her Bachelor of Science from the University of Michigan in 1994, Dr. Shin earned her Doctor of Medicine at George Washington University in 1999. She completed an internship and residency in internal medicine at the University of Maryland in 2002 before completing a cardiovascular disease fellowship at Emory University in 2005. Following this, Dr. Shin remained at Emory to complete an additional fellowship in advanced heart failure and transplant cardiology in 2006.</p><p>Dr. Shin&rsquo;s research focuses on fellow education. She has been principal investigator and co-principal investigator on several funded research projects, and she has presented at invited lectures nationwide. Her work has also been published in numerous peer-reviewed journals, and she has been a reviewer for scientific publications, including the <em>Mayo Clinic Proceedings</em>, the <em>American Journal of Cardiology</em> and <em>Pacing and Clinical Electrophysiology</em>, among others.</p><p>Dr. Shin is board certified by the American Board of Internal Medicine in Cardiovascular Disease, Internal Medicine and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation.</p>

Is Open Scheduling

Off

Aldo L. Schenone

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f4bbeb80-b7a0-11ed-9653-8957fcc72790.jpg

First Name

Aldo

Last Name

Schenone

NPI

1659634160

Faculty ID

17499

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

163167

Visit Type ID

2497

Is Open Scheduling

On

Omar Saeed

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/42a61730-f4e6-11ed-b165-5b052597da41.jpg

First Name

Omar

Last Name

Saeed

NPI

1104003292

Faculty ID

14870

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Heart Failure</p>
<p>Cardiac Transplantation</p>
<p>Mechanical Circulatory Support</p>
<p>Hemolysis</p>
<p>&nbsp;</p>
<p><strong>Education and Training</strong></p>
<p>College: University of California, Berkeley</p>
<p>Medical School: New York Medical College</p>
<p>Residency: Emory University Hospital</p>
<p>Fellowships: Emory University Hospital, Montefiore Medical Center/Albert Einstein College of Medicine</p>
<p>&nbsp;</p>
<p><strong>Grant Support</strong></p>
<p>Hemolysis and Platelet Activation during Continuous Flow Mechanical Circulatory Support (NIH/NHLBI K23HL145140, PI: Saeed)</p>
<p>Jan 2019-Dec 2023</p>
<p>&nbsp;</p>
<p>&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Saeed's clinical focus is on heart failure, heart transplantation and mechanical circulatory support.

Research Focus

Dr. Saeed&rsquo;s research focuses on the mechanisms of hematological and neurological adverse events during mechanical circulatory support.&nbsp;

Elsevier Profile

Selected Publications

<p align="LEFT">1. <strong>Saeed O, </strong>Jakobleff WA, Forest SJ, Chinnadurai T, Mellas N, Rangasamy S, Xia Y, Madan S, Acharya P, Algodi M, Patel SR, Shin J, Vukelic S, Sims DS, Reyes Gil M, Billett HH, Kizer JR, Goldstein DJ, Jorde UP. Hemolysis and Non Hemorrhagic Stroke during Venoarterial Extracorporeal Membrane Oxygenation. The Annals of Thoracic Surgery, 2019.</p>
<p align="LEFT">2. Acharya P, Jakobleff WA, Forest SJ, Chinnaduria T, Mellas N, Patel SR, Kizer JR, Billett HH, Goldstein DJ, Jorde UP, <strong>Saeed O</strong>. Fibrinogen Albumin Ratio and Ischemic Stroke during Venoarterial Extracorporeal Membrane Oxygenation. ASAIO J. 2019.</p>
<p align="LEFT">3. Jorde UP, Shah A, Sims D, Madan S, Siddiqi N, Luke A,<strong> Saeed O</strong>, Patel SR, Murthy S, Shin J, Oviedo J, Watts S, Jakobleff WA, Forest SJ, Vukelic S, Belov D, Puius Y, Minamoto G, Muggia V, Carlese A, Leung S, Rahmaniam M, Leff J, Goldstein D. Continuous-Flow Left Ventricular Asssit Device Survival Improves with Multidisciplinary Approah. The Annals of Thoracic Surgery, 2019.</p>
<p align="LEFT">4. <strong>Saeed O</strong>, Jorde U. Impact and Measurement of Blood Pressure during Continuous Flow Left Ventricular Assist Device Support: The Pressure is On! <em>ASAIO J.</em> 2019.</p>
<p align="LEFT">5. Madan S, Patel SR, <strong>Saeed O</strong>, Sims DB, Shin JJ, Goldstein DJ, Jorde&nbsp;UP. Outcomes of heart transplantation in patients with human immunodeficiency virus. Am J Transplant. 2019</p>
<p align="LEFT">6. <strong>Saeed O,</strong> Patel SR, Jorde UP.&nbsp;Bleeding and Angiogenesis during Continuous Flow Left Ventricular Assist Device (CF LVAD) support - Enter the Von Willebrand Matrix. <em>Circulation Heart Failure</em>. 2018.</p>
<p align="LEFT">7. Farooqi KM, Cooper C, Chelliah A, <strong>Saeed</strong> <strong>O</strong>, Chai PJ, Jambawalikar SR, Lipson H, Bacha EA, Einstein AJ, Jorde UP.&nbsp; 3D Printing and Heart failure: The Present and the Future. <em><span class="jrnl" title="JACC. Heart failure">JACC Heart Fail</span></em>. 2018 Dec 10.</p>
<p align="LEFT">8. Patel SR, Madan S, <strong>Saeed O,</strong> Sims DB, Shin JJ, Nucci C, Borukhov E, Goldstein DY, Jakobleff W, Forest S, Vukelic S, Murthy S, Reinus J, Puius Y, Goldstein DJ, Jorde UP. Cardiac transplantation from non-viremic hepatitis C donors. <em>J Heart Lung Transplant</em>. 2018.</p>
<p align="LEFT">9. Vukelic S, Vlismas P, Patel SR, Xue X, Shitole S, <strong>Saeed O</strong>, Sims DS, Chinnadurai T, Shin J, Forset S, Goldstein DJ, Jorde UP. Digoxin is Associated with Decreased Incidence of Angiodysplasia-related Gastrointestinal Bleeding in&nbsp;Patients with Continuous-Flow Left Ventricular Assist Devices. <em>Circulation Heart Failure</em>. 2018.</p>
<p align="LEFT">10. <strong>Saeed O</strong>, Rangasamy S, Reyes Gil M, Goldstein DJ, Billett HH, Jorde UP, Patel SR.&nbsp; Speed Reduction Does Not Restore High Molecular Weight Multimers of von Willebrand Factor during HeartMate II Support: An In-Vivo Study. <em>ASAIO J</em>. Sep-Oct 2018.</p>
<p align="LEFT">11. Rangasamy S, Madan S, <strong>Saeed O</strong>, Goldstein DJ, Jorde UP, Negassa A, Patel SR. Noninvasive Measures of Pulsatility and Blood Pressure During Continuous-Flow Left Ventricular Assist Device. <span class="jrnl" title="ASAIO journal (American Society for Artificial Internal Organs : 1992)"><em>ASAIO J</em></span>. 2018</p>
<p align="LEFT">12. <strong>Saeed O</strong>, Rangasamy S, Selevany I, MadanS, Fertel J, Eisenberg R, Aljoudi M, Patel SR, Shin JJ, Sims DB, Reyes Gil M, Goldstein DJ, Slepian MJ, Billett HH, Jorde UP.&nbsp;Sildenafil is Associated with Reduced Device Thrombosis and Ischemic Stroke Despite Low Level Hemolysis on Heart Mate II support. <em>Circulation Heart Failure</em>. 2017.</p>
<p align="LEFT">13. Patel SR,&nbsp;<strong>Saeed</strong>&nbsp;<strong>O</strong>, Naftel D, Myers S, Kirklin J,&nbsp;Jorde&nbsp;UP, Goldstein DJ. Outcomes of Restrictive and Hypertrophic cardiomyopathies after LVAD: as INTERMACS Analysis.&nbsp;<em><span class="jrnl" title="Journal of cardiac failure">J Card Fail</span></em>. 2017 Sep 29. pii: S1071-9164(17)31220-4.</p>
<p>14. Madan S, <strong>Saeed</strong> <strong>O</strong>, Vlismas P, Katsa I, Patel SR, Shin JJ, Jakobleff WA, Goldstein DJ, Sims DB,Jorde UP. Outcomes After Transplantation of&nbsp;Donor&nbsp;Hearts With Improving Left&nbsp;Ventricular Systolic&nbsp;Dysfunction. <span class="jrnl" title="Journal of the American College of Cardiology"><em>J Am Coll Cardiol</em></span>. 2017 Sep 5;70(10):1248-1258.&nbsp;</p>
<p>15. Madan S, Patel SR, Vlismas P, <strong>Saeed</strong> <strong>O</strong>, Murthy S, Forest S, Jakobleff W, Sims D, Lamour JM, Hsu DT, Shin J, Goldstein D, Jorde UP. Outcomes of Early Adolescent Donor Hearts in Adult Transplant Recipients. <span class="jrnl" title="JACC. Heart failure"><em>JACC Heart Fail</em></span>. 2017. S2213-1779(17)30320-7.</p>
<p>16. Patel SR, Oh KT, Ogriki T, Sims D, Shin JJ, Madan S, <strong>Saeed O</strong>, Goldstein DJ, Jorde UP.&nbsp; Cessation of Continuous Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding After Heart Transplantation. <em><span class="jrnl" title="ASAIO journal (American Society for Artificial Internal Organs : 1992)">ASAIO J</span></em>. 2017.</p>
<p>17. Madan S, Sims D, <strong>Saeed O</strong>, Patel SR, Shin JJ, Jorde UP. Association of centre volume and in-hospital mortality in heart failure hospitalisations. <em><span class="jrnl" title="Postgraduate medical journal">Postgrad Med J</span></em>. 2017.</p>
<p>18. <strong>Saeed O.</strong>, Jorde U. Advances in Continuous Flow Left Ventricular Assist Device Support for End Stage Heart Failure - A Therapy in Evolution.&nbsp; <em>Cardiology in Review </em>2016.</p>
<p>19. Jermyn R., Alam A., Kvasic J., <strong>Saeed O</strong>., Jorde U. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program. <em>Clinical Cardiology</em>. 2016 Nov.</p>
<p>20. Patel S.R., Madan S., <strong>Saeed O.,</strong> Algodi M., Luke A., Gibber M., Goldstein D.J., Jorde U.P. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous Flow Left Ventricular Assist Devices. <em><span class="jrnl" title="JACC. Heart failure">JACC Heart Failure</span></em>. 2016 Sep 29. pii: S2213-1779(16)30444-9.</p>
<p>21. Madan S., <strong>Saeed O.,</strong> Shin J., Sims D., Goldstein D., Pina I., Jorde U., Patel S. Donor Troponin&nbsp;and Survival after Cardiac Transplantation &ndash; An Analysis of the UNOS Registry. <em>Circ Heart Failure. </em>2016; Jun;9(6).</p>
<p>22. Levin A., <strong>Saeed O.,</strong> Willey, J., Levin C., Fried J., Patel S., Sims D., Nguyen J., Shin J., Topkara V., Colombo P., Goldstein DJ., Yoshifumi N., Takayama H., Uriel N, Jorde U. &nbsp;Watchful Waiting in CF-LVAD Patients with&nbsp;Ongoing Hemolysis is Associated with an Increased Risk for Cerebrovascular Accidents and Death.&nbsp;&nbsp;<em>Circ Heart Failure. </em>2016 May;9(5).</p>
<p>23. Farooqi K., <strong>Saeed O</strong>., Zaidi A., Sanz J., Nielsen J., Hsu D., Jorde U. 3D Printing to Guide Ventricular Assist Device placement in Adults with Congenital Heart Disease and Heart Failure. <em>JACC Heart Failure</em>. 2016;4: 301-11.</p>
<p>24. <strong>Saeed O.</strong>, Shah A., Kargoli F., Madan S., Levin AP., Patel SR., Jermyn R., Guerrero C., Nguyen J., Sims DB., Shin J., Goldstein D., Jorde U. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support. <em>Circ Heart Failure.</em> 2016; 9 (1):e002296.</p>
<p class="Body1">25.<strong> Saeed O</strong>, Jermyn R, Kargoli F., Madan S., Mannem S, Cecilia N, Hassan S., Farooqui S, Bloom&nbsp;M, Mclarty A,^&nbsp;Zolty R, Shin J, D&rsquo;Alessandro D, Goldstein D, Patel&nbsp;S.&nbsp; Blood pressure and adverse events during continuous flow left ventricular assist device support.<em>&nbsp; Circ Heart Failure. </em>2015; 8(3):551-6.</p>
<p class="Body1">26. Habib A, Polavarapu R., Karmali V., Guo L., Van Dam R., Cheng A,. Akahori H., <strong>Saeed O.,</strong> Mastaka N., Pachura K., Hong C., Shin E., Kolodgie F., Virmani, Finn AV. The Hepcidin-Ferroportin1 Axis Controls Toll-Like Receptor 4-Dependent Macrophage Inflammatory Responses in Human Atherosclerotic Plaques. <em>Atherosclerosis</em>. 2015; 241(2) 692-700.</p>
<p>27. <strong>Saeed O.,</strong> Gupta A., Gross J, Palma E.&nbsp; Rate of Cardiovascular Implanted Electronic Device (CIED) re-extraction after recurrent infection. <em>Pacing and Cardiac Electrophysiology. </em>2014<em>; </em>37(8): 963-8.</p>
<p>28. Galvao M., <strong>Saeed O</strong>., Immekus J., Goldstein D., Maybaum S. An International Survey to assess Referral Thresholds for Left Ventricular Assist Device Destination Therapy in Non-Inotrope Dependent patients: Results of the Consensus DT study.&nbsp; <em>Journal of Cardiac Failure. </em>2014; 20(7):492-7.</p>
<p>29. <strong>Saeed O.,</strong> Maybaum S., D&rsquo;Alessandro D., Goldstein D. Patel SR.&nbsp; Aortic Valve Opening and Thrombotic Events with Continuous Flow Left Ventricular Assist Devices. <em>J Heart Lung Transplant</em>. 2014; 33(1):109-12.</p>
<p class="Body1">30. Patel SR., <strong>Saeed O.</strong>, Murthy S., Bhatia V., Shin JJ., Wang D., Negassa A., Pullman J., Goldstein D., Maybaum S. Combining Neurohormonal Blockade with Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support for Myocardial Recovery - A Single Arm Prospective Study<em>. J Heart Lung Transplant.</em> 2013; 32(3): 305-12.</p>
<p>31. <strong>Saeed O.</strong>, Bhatia V., Formica P., Browne A., Aldrich TK., Shin JJ., Maybaum S.&nbsp; Improved exercise performance and skeletal muscle strength after simulated altitude exposure: A novel approach for patients with chronic heart failure. <em>J Card Fail</em>. 2012; 18(5):387-91.</p>
<p>32. Finn AV, <strong>Saeed O</strong>, Virmani R. Macrophage subsets in human atherosclerosis. <em>Circulation Research. </em>2012; 110(9):e64.</p>
<p>33.<strong> Saeed O.</strong>, Otsuka F., Polavarapu R., Karmali V., Weiss D., Davis T., Rostad B.,&nbsp; Pachura K., Adams L., Elliot J., Taylor RW., Narula J., Hong C., Kolodgie F., Virmani R., Finn AV. Pharmacologic suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. <em>Arterioscler Thromb Vasc Biol</em><em>.</em> 2012; 32: 299-307.</p>
<p>34. Finn AV., Nakano M., Polavarapu R., Karmali V., <strong>Saeed O.</strong>,Zhao X., Yazdani S., Davis T., Habib A., Narula J., Kolodgie F, Virmani R. Hemoglobin directs macrophage differentiation and determines lipid uptake human atherosclerotic plaques. <em>J Am Coll Cardiol</em>. 2012; 59(2): 166-177.</p>
<p>35. Wei C., Li L., Torben B., <strong>Saeed O.</strong>, Thabet S., Jansen T., Dikalov S., Weyand C.,Goronzy J., Harrison DG. The role of increased GTP cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation. <em>J Biol Chem. </em>2011; 286(16): 13846-51.&nbsp;</p>
<p>36.<strong> Saeed O</strong>., Yaghmaie F., Garan SA., Gouw A., Voelker M., Freitag W., Sternberg H., Timiras PS. Insulin like Growth Factor -1 immunoreactive cells are selectively maintained in the paraventricular hypothalamus of calorically restricted mice <em>Intl. J.</em> <em>Dev. Neuroscience. </em>2007; 25(1):23-8.</p>
<p>37. Yaghmaie F., <strong>Saeed O.</strong>,Garan S.A., Gouw A., Voelker M., Freitag W., Sternberg H.,&nbsp; Timiras PS. Age dependent loss of Insulin like Growth Factor -1 immunoreactive cells in the supraoptic hypothalamus is reduced in calorically restricted mice. <em>Intl. J. Dev. Neuroscience. </em>2006; 24(7):431-6.</p>

EMR ID

57127

Biography

<p>Omar Saeed, MD, is an Attending Cardiologist at Montefiore and Assistant Professor of Medicine at our Albert Einstein College of Medicine. His clinical focus is on heart failure, heart transplantation and mechanical circulatory support.</p><p>After receiving his Bachelor of Arts in molecular and cellular biology from the University of California, Berkeley in 2003, Dr. Saeed attended New York Medical College, earning his Doctor of Medicine in 2007. He began his postdoctoral training at Emory University Hospital, completing a residency in internal medicine in 2010 and a fellowship in cardiovascular disease in 2011. He then transferred to Albert Einstein College of Medicine. Here he completed a research fellowship in heart failure, transplant and mechanical circulatory support in 2012, a cardiovascular disease fellowship in 2014 and a fourth-year clinical fellowship in advanced heart failure and transplant in 2015.</p><p>Dr. Saeed&rsquo;s research focuses on the mechanisms of hematological and neurological adverse events during mechanical circulatory support. He has published as primary author or as co-author over 50 peer-reviewed manuscripts, and he has presented regionally, nationally and internationally. He also has been an invited manuscript reviewer for many journals, including <em>Haemostasis and Thrombosis, </em>the <em>Journal of Lung and Heart Transplantation</em> and the <em>Journal of Human Immunology</em>.</p><p>Dr. Saeed has received the Martin Cohen award for excellence in cardiovascular fellowship training, the Edmund Sonnenblick award for excellence in heart failure research and the NIH K23 career development award supporting his commitment to patient-oriented research. He is board certified and is a member of several professional organizations, including the American College of Cardiology, the American Society of Echocardiography and the International Society of Heart and Lung Transplant.</p>

Is Open Scheduling

Off

Maria A. Rodriguez

https://assets.montefioreeinstein.org/profiles/images/physphoto/Rodriguez_Maria_MD_420x504.jpg

First Name

Maria

Last Name

Rodriguez

NPI

1588862270

Faculty ID

13048

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>My research interests are in the filed of internetional cardiology and include acute coronary care and stent restenosis. Other interests include gender differences in the management of cardiovascular disease. &nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5524

Is Open Scheduling

On

Zocdoc Link

Carlos J. Rodriguez

https://assets.montefioreeinstein.org/profiles/images/physphoto/Rodriguez_Carlos_MD_420x504.jpg

First Name

Carlos

Last Name

Rodriguez

NPI

1023192820

Faculty ID

16088

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Rodriguez&rsquo;s clinical focus is general cardiology, echocardiology, hypertension, heart failure and cholesterol management.

Research Focus

Expanding on his clinical focus, Dr. Rodriguez&rsquo;s research investigates cardiovascular epidemiology and the impact of psychosocial and behavioral factors on cardiovascular health.

Elsevier Profile

EMR ID

111042

Biography

<p>Carlos Jose Rodriguez, MD, MPH, FAHA, FACC, is Director, Cardiovascular Epidemiology and Director, Clinical Cardiovascular Research at our Albert Einstein College of Medicine. He is also Vice-Chair, Academic Affairs and Attending Physician, Echocardiology and Cardiology at Montefiore. Dr. Rodriguez&rsquo;s clinical focus is general cardiology, echocardiology, hypertension, heart failure and cholesterol management.</p><p>In 1992, Dr. Rodriguez received his Bachelor of Science at the University of Massachusetts at Amherst. He then attended Columbia University College, receiving both his Doctor of Medicine and Master of Public Health degrees in 1996. In 1996, he began a three-year internship and residency in internal medicine at the New York Presbyterian Hospital. He continued training at this institution and completed a fellowship in cardiovascular diseases in 2002. Dr. Rodriguez then completed an advanced clinical and research fellowship in 2003 at Columbia University&rsquo;s College of Physicians and Surgeons.</p><p>Expanding on his clinical focus, Dr. Rodriguez&rsquo;s research investigates cardiovascular epidemiology and the impact of psychosocial and behavioral factors on cardiovascular health. He has shared his work at many of invited presentations and has been published in numerous peer-reviewed journals, abstracts and books.</p><p>From 1989 to 1996, Dr. Rodriguez worked with the United States National Guard as a combat medic. In 2007, he received the Columbia University Medical Center Diversity Faculty Research Award.</p><p>Dr. Rodriguez is board certified by the American Board of Internal Medicine and a member of numerous professional societies, including the American Heart Association, the American College of Cardiology and the American Society of Echocardiography.</p>

Is Open Scheduling

Off

Yogita M. Rochlani

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/07c3c7c0-f4e6-11ed-b68f-a56b34798745.jpg

First Name

Yogita

Last Name

Rochlani

NPI

1427498401

Faculty ID

16762

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Rochlani's clinical areas of focus include cardiac sarcoidosis, myocarditis, cardiac transplantation, and mechanical circulatory support.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Rochlani's research interests include inflammatory cardiomyopathies, particularly cardiac sarcoidosis, donor selection for transplantation, and factors that impact post-transplant longevity, particularly cardiac allograft vasculopathy. She serves as a principal investigator for a study evaluating the phenotypic profiles and natural history of cardiac sarcoidosis, and as the site principal investigator for the Cardiac Sarcoidosis Multicenter Randomized Controlled Trial evaluating immunosuppressive treatment strategies for the treatment of cardiac sarcoidosis.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

111837

Is Open Scheduling

Off